Tell your cancer care team about any changes or problems you notice and about any concerns you have. Conclusions We report herein that a dietary intervention can improve ALL outcome in a preclinical model. If you have or had AML, you probably want to know if there are things you can do to reduce your… Read More »
Acute myeloid leukemia (AML) is a deadly blood cancer that originates in the bone marrow and kills most of its victims within five years. Chemotherapy has been the standard AML treatment for over 40 years, and while it often causes the cancer to go into remission, it rarely completely eliminates the cancerous cells, which then… Read More »
News Consumer News Givlaari Approved for Acute Hepatic Porphyria FRIDAY, Nov. 22, 2019 — On Wednesday, the U.S. Food and Drug Administration announced the approval of Givlaari (givosiran) for the treatment of acute hepatic porphyria. Previous treatment options for this genetic disorder have only provided partial relief from the pain of porphyria attacks, according to… Read More »
By Adam Vaughan A march in London calling for a second EU referendumPaul Smyth/Alamy A case of a man who appears to have experienced acute psychosis triggered by the UK’s 2016 European Union referendum has been described in the journal BMJ Case Reports. The man, in his forties, is the first reported case of an… Read More »
Print this page PRINCETON, N.J.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration (FDA) has expanded the indication for Sprycel ® (dasatinib) tablets to include the treatment of pediatric patients one year of age and older with newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in combination with chemotherapy.1 Sprycel… Read More »
January 03, 2019 This article originally appeared here. Share this content: Rhabdomyolysis is characterized by breakdown of muscle tissue A recently published case report describes the case of a 29-year-old male patient with influenza-induced rhabdomyolysis and highlights the need to assess creatinine kinase (CK) levels of patients hospitalized with influenza. The patient, who had a… Read More »
FDA Approves Daurismo (glasdegib) for Patients with Acute Myeloid Leukemia Print this page November 21, 2018 — The U.S. Food and Drug Administration today approved Daurismo (glasdegib) tablets to be used in combination with low-dose cytarabine (LDAC), a type of chemotherapy, for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adults who are 75… Read More »